Schedule 13G ownership disclosure
N/A
Common Stock, par value $0.001 per share · CUSIP: 92539P101
Event date: 2025-07-25
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- GV 2017, L.P.
Shares: 0.00 · Class: 0.0%
- GV 2017 GP, L.P.
Shares: 0.00 · Class: 0.0%
- GV 2017 GP, L.L.C.
Shares: 0.00 · Class: 0.0%
- GV 2019, L.P.
Shares: 0.00 · Class: 0.0%
- GV 2019 GP, L.P.
Shares: 0.00 · Class: 0.0%
- GV 2019 GP, L.L.C.
Shares: 0.00 · Class: 0.0%
- GV 2023, L.P.
Shares: 0.00 · Class: 0.0%
- GV 2023 GP, L.P.
Shares: 0.00 · Class: 0.0%
- GV 2023 GP, L.L.C.
Shares: 0.00 · Class: 0.0%
- Alphabet Holdings LLC
Shares: 0.00 · Class: 0.0%
- Verily Life Sciences LLC
Shares: 0.00 · Class: 0.0%
- XXVI Holdings Inc.
Shares: 0.00 · Class: 0.0%
- Alphabet Inc.
Shares: 0.00 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-020385
- Form type
- SCHEDULE 13G/A
- Filer
- GV 2017, L.P.
- CIK
- CIK 1733340
- Filed
- Jul 28, 2025
- Reporting period
- Jul 25, 2025
- Description
- Schedule 13G beneficial ownership